Knee gonarthrosis/ Knee osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Knee OA according to the American College of Rheumatology by radiographic examination of the joint under weight bearing; Grade 2 or 3 knee OA confirmed by the participating physician according to the Kellgren & Lawrence criterion; female individuals; age between 50 and 70 years; availability to participate in the treatment plan; BMI between 18.5, normal classification, to 39.9 kg per meter square, obesity grade II
Exclusion criteria
Exclusion criteria: Paticipants with cardiovascular disease, neurological or musculoskeletal disorder that prevents the participant from performing exercises, presence of neoplasms, absolute contraindication to use photobiomodulation; evidence of secondary, inflammatory or metabolic disease, participation of other treatments that may interfere with the results of this study, individuals who have malnutrition or morbid obesity; more than 3 absences throughout the treatment and,or having two consecutive absences
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreased pain, verified by the improvement of 3 points in the Numerical Scale of Pain colllected inicial and end of study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of static and dynamic balance evaluated by Y Balance Test (YBT) and 9-Stair Climb Test (9-step SCT), respectively, in which there is a increase of 20 seconds and 5 centimeters. ;Improvement of maximum oxygen consumption (VO 2 max) and anaerobic threshold of 20%;Improvement of LL strength and functionality through 30s Chair Stand Test (30sCST) and 40m Fast-Paced Walk Test (40mFPWT) with with the increase of 2 repetitions and 5m/s, respectively.;Improvement of Knee Joint Range of Motion (ROM) of 5 degrees measured by goniometer. ;Improvement of quality of life measured by Knee Injury and Osteoarthritis Outcome Score (KOOS), and Medical Outcomes Study 36-item Short Form Health Survey (SF-36), with increase in 20% in both after 8 weeks of treatment. | — |
Countries
Brazil
Contacts
Universidade Federal de São Paulo - UNIFESP/EPM